Endoscopic Botulinum Toxin Injection for Retrograde Cricopharyngeus Dysfunction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prospective controlled study of endoscopic botulinum toxin injection for retrograde cricopharyngeus dysfunction, the inability to belch syndrome
Am. J. Gastroenterol 2024 Nov 26;[EPub Ahead of Print], S Sanagapalli, M Eid, MB Kim, F TudehopeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.